These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12602544)

  • 1. PRL-secreting pituitary adenomas in pregnancy.
    Chiodini I; Liuzzi A
    J Endocrinol Invest; 2003 Jan; 26(1):96-9. PubMed ID: 12602544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin secreting pituitary adenomas, treatment and results.
    Martinez Montes EA
    Prog Clin Biol Res; 1982; 112 Pt A():315-26. PubMed ID: 7163302
    [No Abstract]   [Full Text] [Related]  

  • 3. Prolactin-secreting pituitary adenomas.
    Martin MC; Schriock ED; Jaffe RB
    West J Med; 1983 Nov; 139(5):663-72. PubMed ID: 6659490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pregnancy, delivery and lactation in hyperprolactinemia with prolactin producing pituitary adenoma.
    Kondo I; Suganuma N; Kimura T; Matsuzawa K; Osawa M; Masahashi T; Mizutani S; Narita O; Tomoda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):595-600. PubMed ID: 2754290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathological hyperprolactinemia II. course and diagnostic and therapeutic problems].
    Vermeulen C; Bouallouche A; Brerault JL; Cathelineau G
    Sem Hop; 1982 Oct; 58(36):2085-95. PubMed ID: 6294843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tumoral development of prolactin-secreting pituitary adenomas during pregnancy. Therapeutic approaches (author's transl)].
    Rohmer V; Strauch G; Luton JP; Bricaire H
    Nouv Presse Med; 1981 Dec; 10(46):3783-6. PubMed ID: 6172776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of prolactinomas during pregnancy.
    Witek P; Zieliński G
    Minerva Endocrinol; 2013 Dec; 38(4):351-63. PubMed ID: 24285103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pregnancy in a subject with prolactin-secreting pituitary adenoma during therapy with bromocriptine].
    Passannanti G; Cardone A; Marafioti F; Alvino N
    Riv Ital Ginecol; 1980; 59 Suppl():87-91. PubMed ID: 7347889
    [No Abstract]   [Full Text] [Related]  

  • 9. The treatment of prolactin-secreting pituitary adenomas. An update.
    Limone P; Molinatti GM
    Panminerva Med; 1990; 32(2):56-60. PubMed ID: 2250973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of pituitary adenomas].
    Mezosi E; Nemes O
    Orv Hetil; 2009 Sep; 150(39):1803-10. PubMed ID: 19758960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women with prolactinoma--effect of pregnancy and lactation on serum prolactin and on tumour growth.
    Holmgren U; Bergstrand G; Hagenfeldt K; Werner S
    Acta Endocrinol (Copenh); 1986 Apr; 111(4):452-9. PubMed ID: 3705884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of parlodel treatment on prolactin-secreting tumors of the pituitary].
    Pamfamirov IuK; Golubev VA; Zaets VV; Baluk KhM
    Akush Ginekol (Mosk); 1985 Nov; (11):62. PubMed ID: 2935040
    [No Abstract]   [Full Text] [Related]  

  • 13. How does pregnancy affect the patients with pituitary adenomas: a study on 113 pregnancies from Turkey.
    Karaca Z; Yarman S; Ozbas I; Kadioglu P; Akturk M; Kilicli F; Dokmetas HS; Colak R; Atmaca H; Canturk Z; Altuntas Y; Ozbey N; Hatipoglu N; Tanriverdi F; Unluhizarci K; Kelestimur F
    J Endocrinol Invest; 2018 Jan; 41(1):129-141. PubMed ID: 28634705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between maternal prolactin levels during pregnancy and lactation in women with pituitary adenoma.
    Narita O; Kimura T; Suganuma N; Osawa M; Mizutani S; Masahashi T; Asai M; Tomoda Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 May; 37(5):758-62. PubMed ID: 3998551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory action of bromocriptine and tamoxifen on the growth of human pituitary tumors in soft agar.
    Arafah BM; Wilhite BL; Rainieri J; Brodkey JS; Pearson OH
    J Clin Endocrinol Metab; 1983 Nov; 57(5):986-92. PubMed ID: 6619272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolatin secreting pituitary adenomas.
    Leavens ME; Samaan NA; Larson DL; Jesse RH; Byers RM
    Int Adv Surg Oncol; 1981; 4():277-310. PubMed ID: 6788711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential actions of the dopamine agonist bromocriptine on growth of SMtTW tumors exhibiting a prolactin and/or a somatotroph cell phenotype: relation to dopamine D2 receptor expression.
    Trouillas J; Chevallier P; Remy C; Rajas F; Cohen R; Calle A; Hooghe-Peters EL; Rousset B
    Endocrinology; 1999 Jan; 140(1):13-21. PubMed ID: 9886801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine agonists and pituitary tumor shrinkage.
    Bevan JS; Webster J; Burke CW; Scanlon MF
    Endocr Rev; 1992 May; 13(2):220-40. PubMed ID: 1352243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas.
    Rubinfeld H; Hadani M; Barkai G; Taylor JE; Culler MD; Shimon I
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2257-63. PubMed ID: 16595604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basic fibroblastic growth factor stimulates prolactin secretion from human anterior pituitary adenomas without affecting adenoma cell proliferation.
    Atkin SL; Landolt AM; Jeffreys RV; Diver M; Radcliffe J; White MC
    J Clin Endocrinol Metab; 1993 Sep; 77(3):831-7. PubMed ID: 8370706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.